SUMC in the News (09/25/06)

Print media coverage

Los Angeles Times, 09/25/06
In the lab/ Closer to fooling the eye
Christopher Ta, assistant professor of ophthalmology, is featured in this article on the latest in artificial corneas.

Oakland Tribune, 09/25/06
Scientists are turning bacteria into our best friends
This article discusses the field of probiotics, which involves isolating certain strains of bacteria and administering them to patients for specific purposes. David Relman, associate professor of medicine and of microbiology and immunology, provides comment in this story, which also appears in the Alameda Times-Star.

Hattiesburg American (Hattiesburg, Miss.), 09/25/06
Baby fat: When to rejoice, when to worry
This Associated Press article discusses the lifestyle patterns that can change a healthy chubby baby into an unhealthy obese adult. Thomas Robinson, associate professor of pediatrics and director of the Center for Healthy Weight, provides comment here.

Wisconsin State Journal (Madison, Wis.), 09/25/06
Read, hear stem cell pioneer James Thomson's views on research
In this Q&A, UW-Madison stem cell researcher James Thomson discusses, among other things, California's stem cell institute and its impact on scientists. Although Stanford is not referenced, this article may be of interest to readers.

New York Times Magazine, 09/24/06
What if it's (sort of) a boy and (sort of) a girl?
Katrina Karkazis, senior research scholar at the Stanford Center for Biomedical Ethics (SCBE), is quoted in this feature on intersex births.

Chicago Tribune, 09/24/06
You can't put a price on a kid's brain
This article discusses a recent policy paper written by Eric Knudsen, the Edward C. and Amy H. Sewall Professor, and other researchers that shows that positive interactions with nurturing adults can help a child's brain thrive. Knudsen is quoted here.

Nashville Tennessean, 09/23/06
MD perks from drug industry need to end
This opinion piece expresses support for a new Stanford policy aimed at limiting the potential influence of pharmaceutical and other biomedical companies in its day-to-day clinical and educational activities.

Orange County Register, 09/23/06
UCI seeks millions in stem cell funds (No online version available)
UC Irvine is asking the state for almost $26 million for human embryonic stem cell research. Stanford is referenced here.

Los Angeles Times, 09/23/06
Govt. oversight of prescription drugs needs overhaul
An Institute of Medicine blue-ribbon panel has concluded that the government's system for protecting the public from dangerous side effects of prescription drugs needs a sweeping overhaul. In a report released Sat., the panel criticized both the FDA and the pharmaceutical industry, saying they "do not consistently demonstrate accountability and transparency to the public by communicating safety concerns in a timely and effective fashion." Although Stanford is not referenced, this article may be of interest to readers.

HealthDay, 09/22/06
Stem cell trial for neurodegenerative pediatric disease to get under way
This article discusses how a Phase I trial to test the safety of stem cell transplants to treat Batten disease is about to get started at Oregon Health & Science University's Doernbecher Children's Hospital. Stanford doctors helped develop the protocol for the trial.

San Francisco Business Times, 09/22/06
Health challenge (No online version available)
This article discusses how NIH budget cutbacks threaten work at Stanford and UC. Harry Greenberg, the Joseph D. Grant Professor and senior associate dean of research, provides comment.

Broadcast media coverage

WBRZ-TV (Baton Rouge, La.), 09/24/06
Older women who simply reduce the amount of total fat in their diet won't generally lower their risk of breast or colorectal cancer or heart disease, according to recent findings from the federally funded Women's Health Initiative. Marcia Stefanick, professor of medicine at the Stanford Prevention Research Center, was featured in this segment.

KQED-FM, 09/22/06

This segment discussed the prevalence of hepatitis B in Asian-American communities. Samuel So, the Lui Hac Minh Professor and director of the Asian Liver Center, was interviewed.

During a separate segment, David Magnus, director of the SCBE, commented on California's long waiting lists for organ transplants.

Stanford Medicine Resources:

Footer Links: